Back to results
US 8,569,382 B2Granted
Isolated compounds from Phaleria macrocarpa as anti-cancer agents
AssigneePt. Dexa Medica
InventorsAsep Aripin, Poppy Firzani Arifin, Raymond R. Tjandrawinata
Life of this patent
Estimating the term…
Abstract
The invention concerns compounds DLBS1425E2.2 and DLBS1425F1 isolated and identified from the extract of the plant Phaleria macrocarpa (Scheff.) Boerl. The invention also relates to the use of said compounds, either as a single active compound or in combination, in a pharmaceutical dosage form that has anti-proliferative activity of cancer cells, and its use relating to female related diseases. Formula (I).
Claims4
A method of treating cancer, comprising:
- administering to a subject in need thereof an effective amount of E2.2 compound, wherein said amount is effective as an anti-proliferative agent.
A method of treating cancer, comprising:
- administering to a subject in need thereof an effective amount of E2.2 compound, wherein said amount is effective as an apoptosis inducer.
Dependencies are inferred from the claim text.